Breast Cancer in Young Women Sixth International Consensus Symposium

Background

Breast cancer in young women is a complex disease, occurring when women are at the peak of their reproductive years, family life and careers. Being a somewhat rare disease, the optimal management of these patients is based on scientific data derived from clinical trials mostly conducted on older women.

Many aspects of breast cancer in young women are therefore poorly understood (e.g., aetiology and biology among others) and research is much needed in this field. In addition, young women have many years ahead of them to suffer the long-term effects of treatment and specific survivorship issues (fertility and job, among others).

The Breast Cancer in Young Women Sixth International Consensus Symposium 2022 will address challenges and opportunities in different cultural and economic settings, follow-up care, diagnostic and treatment guidelines, from early to advanced breast cancer and survivorship, updating the available evidence and generating future research concepts and collaborations with an interactive, international, and collaborative spirit. It will also include a Consensus Session that will form the basis for a Consensus Guidelines Manuscript to be published after the Symposium.

Learning Objectives

• In-depth learning and update of the scientific and clinical aspects of breast cancer in young women
• Highlighting of the importance of multi-disciplinary management
• Focus on clinical research priorities and future perspectives, involving patients’ advocates in setting the agenda
• Participation in the discussion of consensus guidelines

Target Group

Medical Oncologists – Surgeons – Gynaecologists – Radiation Oncologists – Breast Radiologists – Pathologists – iOnco-geneticists – Nurses – Patient Advocates – Psycho-oncologists.

Format

The Symposium will be held online with the participation of world-renowned Experts.
The event will be accessible to the audience by registering on the SPCC e-learning platform OncoCorner. Material will remain available on-demand on the OncoCorner website.

Content

The event will consist of:

• On-demand material: recorded lectures, available 2 weeks before the start of the event
• Consecutive 2-day live sessions

Request for Continuing Medical Education accreditation will be submitted to ACOE.

Under the auspices of:

Organising Secretariat

Sharing Progress in Cancer Care
Via Vincenzo Vela, 6
6500 Bellinzona – Switzerland

Annalisa Musco
annalisa.musco@spcc.net - Tel: +39 331 6832686

CME Accreditation and Certificates

Application for CME accreditation will be submitted to the Accreditation Council of Oncology in Europe (ACOE).

Participants will be issued a certificate of attendance (minimum attendance: 75% of the entire course). An online evaluation questionnaire and learning assessment test will need to be completed in order to get the certificate that will be issued by email.

Acknowledgements

Sharing Progress in Cancer Care wishes to express its appreciation to Debiopharm, Lilly and Pfizer for their unrestricted support.

Event attendance will be free of charge, but registration is required by Wednesday 5 October 2022.
Registrations are open via https://www.oncocorner.net/online-events/50#prog.

INVITED FACULTY
Frédéric Amant, University Hospitals of Leuven, BE
Hatem A. Azim Jr., Monterrey Institute of Technology, Monterrey, MX
Linda Battistuzzi, University of Genoa, IT
Michal Braun, Sharett Institute of Oncology, Hadassah University Hospital, Jerusalem, IL
Fatima Cardoso, Champalimaud Clinical Center, Lisbon, PT
Maria-João Cardoso, Champalimaud Foundation, Lisbon, PT
Giuseppe Curigliano, European Institute of Oncology, Milan, IT
Rebecca A. Dent, National Cancer Center Singapore, SG
Alexandru Eniu, Interdisciplinary Cancer Service, HRC Hopital Riviera-Chablais, Rennaz, CH
Karen Gelmon, BC Cancer Agency, Vancouver, CA
Oreste D. Gentilini, IRCCS Ospedale San Raffaele, Milan, IT
Matteo Lambertini, San Martino Hospital and University of Genoa, IT
Hong Liu, Tianjin Medical University Cancer Institute & Hospital (TJMUCH), Chinese Anti-Cancer Association (CACA), Tianjin, CN
Qiang Liu, Sun Yat-sen Memorial Hospital,Sun Yat-sen University, Breast Tumour Centre, Guangzhou, CN
Jennifer Merschdorf, Young Survival Coalition, New York, US
Olivia Pagani, European School of Oncology and University of Geneva and Lugano, CH
Shani Paluch-Shimon, Hadassah University Hospital - Sharett Institute of Oncology, Jerusalem, IL
Ann H. Partridge, Harvard Medical School and Dana-Farber Cancer Institute, Boston, US
Fedro Alessandro Peccatori, European Institute of Oncology, Milano, IT
Philip Poortmans, Saint Augustus University Campus and Antwerp University, Antwerp, BE
Giancarlo Pruneri, IRCCS National Cancer Institute, Milan, IT
Shoshana M. Rosenberg, Dana-Farber Cancer Institute and Weill Cornell Medicine, New York, US
Monica Ruggeri, International Breast Cancer Study Group, Program for Young Patients, Bern, CH
Elzbieta Senkus, Medical University of Gdansk, PL
Tanja Spanic, Europa Donna Slovenia and Europa Donna-The European Breast Cancer Coalition, Ljubljana, SI
Virpi Sulosaari, European Oncology Nursing Society (EONS) and Turku University of Applied Sciences, Turku, FI
Clare Turnbull, The Institute of Oncology Research and Royal Marsden NHS Foundation Trust, London, UK